|4Nov 22, 5:18 PM ET

Roemer Alan S. 4

4 · NexImmune, Inc. · Filed Nov 22, 2023

Insider Transaction Report

Form 4
Period: 2023-11-21
Transactions
  • Sale

    Common Stock

    2023-11-21$2.16/sh3,833$8,2873,992 total
  • Sale

    Common Stock

    2023-11-22$1.94/sh3,992$7,7580 total
Footnotes (2)
  • [F1]The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.39 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.
  • [F2]The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.05 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION